Collaborating with govt agencies to develop treatment for Covid-19: Cipla

The company is offering drugs, which have shown potency in treating Covid-19, in partnership with its global partners

Drug major Cipla is working with government agencies to develop a treatment for Covid-19 while ramping up the production of various life-saving essential drugs, according to the company's chairman, Y K Hamied.

Sharing information with shareholders in the drug firm's annual report for 2019-20, Hamied said the company was at the forefront in the fight against Covid-19.

"Cipla is collaborating with the Council of Scientific & Industrial Research (CSIR), Indian Institute of Chemical Technology (IICT), Indian Council of Medical Research (ICMR) and the Ministry of Health to develop medications for the treatment of Covid-19," Hamied said.

Meanwhile, the company is offering drugs, which have shown potency